title: The "artificial" docetaxel space: the evolving treatment paradigm of metastatic castration-resistant prostate cancer.
authors.affiliation: Bladder Cancer Center at DFCI, Boston, MA, USA.
authors.forename: Anna
authors.initials: A
authors.lastname: Orsola
authors.affiliation: Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, MA, USA; University Hospital Del Mar-IMIM, Barcelona, Spain. Electronic address: joaquim_bellmunt@dfci.harvard.edu.
authors.forename: Joaquim
authors.initials: J
authors.lastname: Bellmunt
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000188:drug therapy*; D006801:Humans; D008297:Male; D064129:Prostatic Neoplasms, Castration-Resistant / Q000188:drug therapy*